166 related articles for article (PubMed ID: 27650062)
1. Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.
Helman R; Pereira WO; Marti LC; Campregher PV; Puga RD; Hamerschlak N; Chiattone CS; Santos FPS
Br J Haematol; 2018 Feb; 180(3):443-445. PubMed ID: 27650062
[No Abstract] [Full Text] [Related]
2. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome.
Colaizzo D; Amitrano L; Tiscia GL; Iannaccone L; Gallone A; Grandone E; Guardascione MA; Margaglione M
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):459-62. PubMed ID: 18600100
[TBL] [Abstract][Full Text] [Related]
4. JAK2V617F mutation in patients with splanchnic vein thrombosis.
Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
[TBL] [Abstract][Full Text] [Related]
5. JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation.
Plumé G; Vayá A; Ferrando F; Mira Y; Orbis F
Thromb Haemost; 2007 Sep; 98(3):681-2. PubMed ID: 17849060
[No Abstract] [Full Text] [Related]
6. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
7. A novel subtype of myeloproliferative disorder? JAK2V617F-associated hypereosinophilia with hepatic venous thrombosis.
Dasari S; Naha K; Hande M; Vivek G
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23997080
[TBL] [Abstract][Full Text] [Related]
8. Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders.
Smira G; Gheorghe L; Iacob S; Coriu D; Gheorghe C
J Gastrointestin Liver Dis; 2010 Mar; 19(1):108-9. PubMed ID: 20361090
[No Abstract] [Full Text] [Related]
9. JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.
Wang H; Sun G; Zhang P; Zhang J; Gui E; Zu M; Jia E; Xu H; Xu L; Zhang J; Lu Z
J Gastroenterol Hepatol; 2014 Jan; 29(1):208-14. PubMed ID: 23980667
[TBL] [Abstract][Full Text] [Related]
10. JAK2V617F and prothrombin G20210A gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia.
Musallam KM; Aoun EG; Mahfouz RA; Khalife M; Taher AT
Clin Appl Thromb Hemost; 2010 Aug; 16(4):472-4. PubMed ID: 19223280
[TBL] [Abstract][Full Text] [Related]
11. Endothelial JAK2
Poisson J; Hilscher MB; Tanguy M; Hammoutene A; Boulanger CM; Villeval JL; Simonetto DA; Valla D; Shah VH; Rautou PE
J Hepatol; 2018 May; 68(5):1086-1087. PubMed ID: 29360553
[No Abstract] [Full Text] [Related]
12. Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?
Mishchenko E; Tadmor T; Schiff E; Attias D; Polliack A
Am J Hematol; 2011 Feb; 86(2):223-4. PubMed ID: 21264914
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
14. Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
Spivak JL; Moliterno AR; Silver RT
N Engl J Med; 2006 Aug; 355(7):737; author reply 738. PubMed ID: 16914715
[No Abstract] [Full Text] [Related]
15. JAK2 V617F Mutation Testing in Patients Presenting With Hepatic and Portal Vein Thrombosis.
Foucar CE; Stein BL
JAMA; 2017 Jun; 317(21):2228-2229. PubMed ID: 28586872
[No Abstract] [Full Text] [Related]
16. MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction.
Bergamaschi GM; Primignani M; Barosi G; Fabris FM; Villani L; Reati R; Dell'era A; Mannucci PM
Blood; 2008 Apr; 111(8):4418. PubMed ID: 18398061
[No Abstract] [Full Text] [Related]
17. [JAK2 mutation and thrombosis - recommendations for screening].
Linnemann B; Lindhoff-Last E
Dtsch Med Wochenschr; 2011 Dec; 136(48):2454-7. PubMed ID: 22109574
[No Abstract] [Full Text] [Related]
18. The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.
Sozer S; Fiel MI; Schiano T; Xu M; Mascarenhas J; Hoffman R
Blood; 2009 May; 113(21):5246-9. PubMed ID: 19293426
[TBL] [Abstract][Full Text] [Related]
19. Laser-capture microdissection and analysis of liver endothelial cells from patients with Budd-Chiari syndrome.
Sozer S; Hoffman R
Methods Mol Biol; 2011; 755():405-15. PubMed ID: 21761323
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.
Qi X; Zhang C; Han G; Zhang W; He C; Yin Z; Liu Z; Bai W; Li R; Bai M; Yang Z; Wu K; Fan D
J Gastroenterol Hepatol; 2012 Jun; 27(6):1036-43. PubMed ID: 22142461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
